Quipazine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Quipazine
Quipazine.png
Systematic (IUPAC) name
2-piperazin-1-ylquinoline
Clinical data
Identifiers
4774-24-7 YesY
None
PubChem CID 5011
IUPHAR ligand 173
ChemSpider 4836 N
UNII 4WCY05C0SJ N
ChEMBL CHEMBL18772 N
Chemical data
Formula C13H15N3
213.278 g/mol
 N (what is this?)  (verify)

Quipazine is a piperazine drug used in scientific research. It is a moderately selective serotonin receptor agonist, binding to a range of different serotonin receptors, but particularly to the 5-HT2A[1] and 5-HT3.[2]

See also[edit]

References[edit]

  1. ^ Smith RL, Barrett RJ, Sanders-Bush E. Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor. Journal of Pharmacology and Experimental Therapeutics. 1995 Nov;275(2):1050-7. PMID 7473132
  2. ^ Cappelli A, Anzini M, Vomero S, Mennuni L, Makovec F, Doucet E, Hamon M, Bruni G, Romeo MR, Menziani MC, De Benedetti PG, Langer T. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives. Journal of Medicinal Chemistry. 1998 Feb 26;41(5):728-41. PMID 9513601